The UK pharmaceutical giant has announced a landmark $15bn China investment during the UK prime minister’s visit, marking its largest expansion yet to boost manufacturing, R&D and biotech collaboration.
AstraZeneca unveils $15bn China investment during Keir Starmer visit
